Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 589 Eighth Avenue
  • 6thFloor
  • New York, NY 10018

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001020475
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 7374 - Data processing and preparation
Incorporated In: DE, USA
Year of Inc. 1996
Employees Not Available
Company Officers/Contacts
Lee Lazarus COO
Sara Ellen Breslau Senior VP
Joshua Rizack Chief Restr. Officer
John Sweeney Finance & Controlling
Company Directors
Andrew Foote
Clement S. Dwyer, Jr.
James K. O'Brien
Company Notes
  • Note = On April 14, 2017, the Company and its wholly-owned subsidiary, Grand Card, LLC, filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Florida
  • Formerly=NorWes Tech, Inc. until 3-2012
  • Formerly=Pacific Biomarkers, Inc. until 9-2011
  • Formerly=Pacific Biometrics, Inc. until 3-2010
Service Providers
Accounting/Auditing Firm
EisnerAmper LLP
750 Third Avenue
New York, NY, 10017
United States

Legal Counsel
Olshan Frome Wolosky LLP
Park Avenue Tower
65 East 55th Street
New York, NY, 10022
United States

Akerman LLP
666 Fifth Avenue
20th Floor
New York, NY, 10103
United States

Investor Relations Firm
Not Available
GPCMQ Security Details
Share Structure
Market Value1 $80,907 a/o Aug 18, 2017
Authorized Shares 2,156,500,000 a/o Dec 31, 2016
Outstanding Shares 202,268,582 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 27,703,403 a/o Dec 31, 2016
Par Value 0.01
Shareholders of Record 222 a/o Dec 31, 2016
Short Selling Data
Short Interest 64,175 (100%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security